Singapore Pharmaceuticals and Healthcare Report Q2 2015

Date: February 18, 2015
Pages: 132
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: SEE9BCE79CFEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceutical companies due to minimal levels of operational risks and the government's support for the industry. The pharmaceutical industry has been a key pillar of the country's economy and we believe its importance will continue to grow as traditional drivers such as electronic manufacturing slow.

Headline Expenditure Projections
  • Pharmaceuticals: SGD1.041bn (USD822mn) in 2014 to SGD1.097bn (USD836mn) by 2015; +5.4% in local currency terms and +1.7% in USD terms.
  • Healthcare: SGD19.31bn (USD15.24bn) in 2014 to SGD20.97bn (USD15.97bn) by 2015; +8.6% in local currency terms and +4.8% in USD terms.
BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Singapore 2011-2019)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Singapore 2011-2019)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Singapore 2011-2019)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Singapore 2011-2019)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Singapore 2011-2019)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Singapore 2011-2019)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Singapore 2011-2019)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Singapore 2011-2019)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Singapore 2013-2019)
  Table: Pharmaceutical Trade Data And Forecasts Local Currency (Singapore 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
MAS Keeps SGD On Moderate Appreciatory Path
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
Singapore Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
  Table: Estimated Number Of New Cases Of Cancer In Singapore
Healthcare Sector
Financing
  Table: Health Funding Sources In Singapore (SGDmn)
Healthcare Insurance
Healthcare Company Developments
  Table: Healthcare Resources
  Table: Healthcare Activity
  Table: Healthcare Personnel
Medical Tourism
International Healthcare Collaboration
Research & Development
Bioscience Sector
Research & Development Activity
Clinical Trials
Regulatory Development
  Table: Regulatory Process Time Taken Under The CECA And Under The Abridged GDA
Regional Harmonisation
Intellectual Property Issues
Trade Agreements
Pricing And Reimbursement Regime
Competitive Landscape
Pharmaceutical Industry
  Table: Pharmaceutical Manufacturing In Singapore, 2004-2012
Research-based Industry
  Table: Multinational Pharmaceutical Firms' Presence In Singapore
  Table: Leading Generic Drugmakers In Singapore
Traditional Chinese Medicine
Pharmaceutical Distribution
Pharmaceutical Wholesaling
Pharmaceutical Retail Sector
Company Profile
Baxter
GlaxoSmithKline
Haw Par
Merck & Co
MerLion
Novartis
Pfizer
Sanofi
Sci Gen
Veredus Laboratories
Demographic Forecast
Demographic Outlook
  Table: Population Headline Indicators (Singapore 1990-2025)
  Table: Key Population Ratios (Singapore 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Singapore 1990-2025)
  Table: Population By Age Group (Singapore 1990-2025)
  Table: Population By Age Group % (Singapore 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Singapore Pharmaceuticals and Healthcare Report Q2 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: